| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.22 | 0.0006 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |